Inventors as investigators: The ethics of patents in clinical trials

Academic Medicine

Volumn 82, Issue 1, 2007, Pages 24-31

  Kimmelman, Jonathan ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; ETHICS; FUNDING; HEALTH CARE ORGANIZATION; HOSPITAL MANAGEMENT; MEDICAL LITERATURE; PERSONNEL; POLICY; PRIORITY JOURNAL; RESEARCH SUBJECT;

EID: 33845987724     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ACM.0000250027.48685.ca     Document Type: Article

References (39)

1. American Society of Gene Therapy. Policy of the American Society of Gene Therapy Financial Conflict of Interest in Clinical Research. Available at: (http://www.asgt.org/position_statements/conflict_of_interest.html). Accessed September 18, 2006.
2. Marshall E. Gene therapy's web of corporate connections. Science. 2000;288:954-955.
3. Gelsinger v. Trustees of the University of Pennsylvania. (Phila Cnty Ct of CP filed September 18, 2000), Sherman, Silverstein, Kohl, Rose and Podolsky Law Offices. Available at: (http://www.sskrplaw.com/links/healthcare2.html). Accessed September 18, 2006.
4. Wilson JM, inventor. Method of treating liver disorders. WIPO patent WO9730167. August 21, 1997.
5. National Institutes of Health. NIH Awards to Medical Schools by Rank, Fiscal Year 2003. Available at: (http://grants1.nih.gov/grants/award/rank/ medttl03.htm). Accessed September 18, 2006.
6. CIHR Funding [database online]. Ottawa, Canada: Canadian Institutes of Health Research; 2003. Available at: (http://webapps. cihr-irsc.gc.ca/funding/ Search?p_language= E&p_version=CIHR). Updated August 18, 2006.
7. Thomson Scientific. Journal List 2004. Available at: (http://scientific. thomson.com/media/presentrep/acropdf/documentsolution. pdf). Accessed September 18, 2006.
8. U.S. Department of Health and Human Services. Draft Interim Guidance: Financial Relationships in Clinical Research: Issues for Institutions, Clinical Investigators, and IRBs to Consider When Dealing with Issues of Financial Interests and Human Subject Protection. Available at: (http://www.hhs.gov/ohrp/ humansubjects/finreltn/finguid.htm). Accessed September 18, 2006.
9. U.S. Department of Health and Human Services. Final Guidance Document: Financial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection. Available at: (http://www.hhs.gov/ohrp/ humansubjects/finreltn/fguid.pdf). Accessed September 18, 2006.
10. 21 C.F.R. Sect. 54.4(a)(3)(iii).
11. 21 C.F.R. 54.2.(e).
12. Interagency Advisory Panel on Research Ethics. Tri-council Policy Statement: Ethical Conduct for Research Involving Humans. Section 4. Available at: (http://www.pre.ethics. gc.ca/english/pdf/TCPS%20October%202005_E.pdf). Accessed September 18, 2006.
13. 35 U.S.C. § 202.(c)(7)(B).
14. Bloomberg CA. Developing an intellectual property portfolio for the academic or not-for-profit institution. Nat Biotechnol. 2005;23:119-121.
15. Slaughter S, Rhoades G. Academic Capitalism and the New Economy: Markets, State and Higher Education. Baltimore: Johns Hopkins University Press; 2004.
16. 35 U.S.C. § 102(a).
17. Teitelbaum R, Cohen MS. Publish and perish: what constitutes a bar under the patent laws. Nat Biotechnol. 2004;22:1449-1450.
18. Shane S. Selling university technology: patterns from MIT. Manage Sci. 2002;48:122-137.
19. Green L, Myerson J. A discounting framework for choice with delayed and probabilistic rewards. Psychol Bull. 2004;130:769-792.
20. Bray MJ, Lee JN. University revenues from technology transfer: licensing fees vs. equity positions. J Business Venturing. 2000;15:385-392.
21. Thursby JG, Jensen R, Thursby MC. Objectives, characteristics and outcomes of university licensing: a survey of major U.S. universities. J Technol Transf. 2001;26:59-72.
22. Kim SY, Millard RW, Nisbet P, Cox C, Caine ED. Potential research participants' views regarding researcher and institutional financial conflicts of interest. J Med Ethics. 2004;30:73-79.
23. Sharpe VA. Science, bioethics and the public interest: on the need for transparency. Hastings Cent Rep. 2002;32:23-26.
24. Barnes M, Florencio PS. Financial conflicts of interest in human subjects research: the problem of institutional conflicts. J Law Med Ethics. 2002;30:390-402.
25. Lemmens T, Freedman B. Ethics review for sale? Conflict of interest and commercial research review boards. Milbank Q. 2000;78:547-584.
26. Wood A, Grady C, Emanuel EJ. Regional ethics organizations for protection of human research participants. Nat Med. 2004;10:1283-1288.
27. National Institutes of Health. Guidelines for Research Involving Recombinant DNA Molecules. Bethesda, MD: National Institutes of Health; 2002.
28. National Institutes of Health. NIH Roadmap. Available at: (www.nihroadmap.nih.gov). Accessed September 18, 2006.
29. AAMC Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research. Acad Med. 2003;78:225-236.
30. Alpert JS, Shine KI, Adams RJ, et al. Task force 1: The ACCF and AHA codes of conduct in human subjects research. J Am Coll Cardiol. 2004;44:1724-1728.
31. Califf RM, Nissen SE, DeMaria AN, et al. Task force 2: investigator participation in clinical research. J Am Coll Cardiol. 2004;44:1729-1736.
32. Jacobs AK, Lindsay BD, Bellande BJ, et al. Task force 3: disclosure of relationships with commercial interests: policy for educational activities and publications. J Am Coll Cardiol. 2004;44:1736-1740.
33. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement: oversight of clinical research. J Clin Oncol. 2003;21:2377-2386.
34. American Society of Clinical Oncology. Revisions of and clarifications to the ASCO conflict of interest policy. J Clin Oncol. 2006;24:517-518.
35. Redmond DF, Freeman T. American Society for Neural Transplantation and Repair. The American Society for Neural Transplantation and Repair Considerations and guidelines for studies of human subjects. The practice committee of the society. Approved by council. Cell Transplant. 2001;10:661-664.
36. Task Force on Research Accountability, American Association of Universities. Report on Individual and Institutional Financial Conflict of Interest. Washington, DC: American Association of Universities; 2001.
37. Luce JM, Cook DJ, Martin TR, et al. The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med. 2004;170:1375-1384.
38. Komesaroff PA, Bach MA, Danoff A, et al. The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interests, October 2003. Endocrinology. 2004;145:3032-3041.
39. Pharmaceutical Research and Manufacturers of America. Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results. Washington, DC: Pharmaceutical Research and Manufacturers of America; 2004.10.1097/01.ACM.0000249971.60508.0e